Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Obesity biotech Kailera’s record-breaking IPO

 April 17, 2026

Pharmaphorum

When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has now been fulfilled.

M&A / DealsRead full story

Post navigation

S16 Ep53: Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting →
← Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com